Table 1.
Demographical and epidemiological data of the 129 tuberculosis patients from Guadeloupe in function of their place of birth
| Parameters studied | Total number (%) (n = 129) | Foreign-born patients number (%) (n = 66) | French patients number (%) (n = 63) | p | |
|---|---|---|---|---|---|
| Sex |
|
|
|
|
|
| |
male |
77 (59.7) |
35 (53.0) |
42 (66.7) |
NS |
| |
female |
52 (40.3) |
31 (47.0) |
21 (33.3) |
|
| |
unknown |
0 |
0 |
0 |
|
| Age group |
|
|
|
|
|
| |
0-14 years |
1 (0.8) |
1 (1.5) |
0 (0) |
<0.001 |
| |
15-24 years |
12 (9.3) |
10 (15.2) |
2 (3.2) |
|
| |
25-39 years |
44 (34.1) |
26 (39.4) |
18 (28.6) |
|
| |
40-59 years |
46 (35.7) |
26 (39.4) |
20 (31.7) |
|
| |
>60 years |
26 (20.2) |
3 (4.5) |
23 (36.5) |
|
| |
unknown |
0 |
0 |
0 |
|
| Employment a |
|
|
|
|
|
| |
no |
65 (70.7) |
37 (72.5) |
28 (68.3) |
NS |
| |
yes |
27 (29.3) |
14 (27.5) |
13 (31.7) |
|
| |
unknown |
37 |
15 |
22 |
|
| Positive HIV status |
|
|
|
|
|
| |
no |
77 (75.7) |
34 (61.8) |
43 (91.5) |
<0.001 |
| |
yes |
25 (24.5) |
21 (38.2) |
4 (8.5) |
|
| |
unknown |
27 |
11 |
16 |
|
| Smoker |
|
|
|
|
|
| |
no |
76 (80.0) |
45 (83.3) |
31 (75.6) |
NS |
| |
yes |
19 (20.0) |
9 (16.7) |
10 (24.4) |
|
| |
unknown |
34 |
12 |
22 |
|
| Excessive alcohol user b |
|
|
|
|
|
| |
no |
69 (71.9) |
47 (85.5) |
22 (53.7) |
<0.001 |
| |
yes |
27 (28.1) |
8 (14.5) |
19 (46.3) |
|
| |
unknown |
33 |
11 |
22 |
|
| Drug user |
|
|
|
|
|
| |
no |
81 (87.1) |
50 (96.2) |
31 (75.6) |
<0.01 |
| |
yes |
12 (12.9) |
2 (3.8) |
10 (24.4) |
|
| |
unknown |
36 |
14 |
22 |
|
| Prior history of active TB |
|
|
|
|
|
| |
no |
90 (87.4) |
53 (93.0) |
37 (80.4) |
NS |
| |
yes |
13 (12.6) |
4 (7.0) |
9 (19.6) |
|
| |
unknown |
26 |
9 |
17 |
|
| Sputum AFB smear result |
|
|
|
|
|
| |
no |
38 (29.5) |
21 (31.8) |
17 (27.0) |
NS |
| |
yes |
91 (70.5) |
45 (68.2) |
46 (73.0) |
|
| |
unknown |
0 |
0 |
0 |
|
| Drug resistance |
|
|
|
|
|
| |
no |
119 (92.2) |
61 (92.4) |
58 (92.1) |
NS |
| |
yes |
10 (7.8) |
5 (7.6) |
5 (7.9) |
|
| |
unknown |
0 |
0 |
0 |
|
| Localization of TB c |
|
|
|
|
|
| |
pulmonary |
114 (88.4) |
54 (81.8) |
60 (95.2) |
<0.02 |
| |
extrapulmonary |
15 (11.6) |
12 (18.2) |
3 (4.8) |
|
| |
unknown |
0 |
0 |
0 |
|
| Treatment outcome d |
|
|
|
|
|
| |
completed treatment / cured |
63 (55.8) |
37 (66.1) |
26 (45.6) |
NS |
| |
died before treatment completed |
17 (15.0) |
6 (10.7) |
11 (19.3) |
|
| |
lost to follow up |
33 (29.2) |
13 (23.2) |
20 (35.1) |
|
| unknown | 16 | 10 | 6 | ||
a Employment: the “yes” includes patients who answered positively to the question “Do you currently have a regular professional activity?”
b Excessive alcohol user: “yes” concerns patients drinking more than 4 glasses of alcoholic beverages per day.
c Localization of TB: Pulmonary, patients without any extrapulmonary manifestation of TB; Extrapulmonary, patients with extrapulmonary or disseminated TB, as well as with combined manifestations of extrapulmonary and pulmonary TB.
d Treatment outcome: “completed treatment” includes only cured patients.
Abbreviations: NA Not Applicable, NS Non Significant (significance level below 0.05).